Biocon Case Study Pdf Economies Business Biocon india group should expand its operations through clinigene, its clinical research subsidiary, to capture opportunities in the growing clinical trials market in india. This document contains a case study submitted by students at iisc bangalore regarding biocon india group. it discusses expanding biocon's operations through its subsidiary clinigene.
Case Of Biocon R D Project Pdf Research And Development Project After unilever acquired biocon ireland in 1989, biocon india purchased unilever’s shareholding in the company in 1998 and established its independence as a privately owned entity. over the years, biocon became an international name for producers of generic pharmaceutical drugs. On studocu you find all the lecture notes, summaries and study guides you need to pass your exams with better grades. Biocon invested heavily in developing its biosimilar pegfilgrastim (used to boost white blood cells during chemotherapy). however, the drug faced delays in clinical trials and regulatory approvals, increasing r&d costs and delaying revenue generation. Expertise in manufacturing enzymes led to mass production of generic drugs, which in turn gave biocon the experience to establish syngene, a subsidiary contract research organization (cro) serving the global pharmaceutical market.
Biocon Case Study Group 1 Doc Biocon invested heavily in developing its biosimilar pegfilgrastim (used to boost white blood cells during chemotherapy). however, the drug faced delays in clinical trials and regulatory approvals, increasing r&d costs and delaying revenue generation. Expertise in manufacturing enzymes led to mass production of generic drugs, which in turn gave biocon the experience to establish syngene, a subsidiary contract research organization (cro) serving the global pharmaceutical market. Analyze the biocon india group case study, exploring advantages, disadvantages, and expansion options in the indian pharmaceutical market. get insights now!. 4) as biocon started its very first industrial infrastructure in bangalore, but now for the better future they should look beyond for the other available places for new development in india. Biocon india group has just formed a new subsidiary, clinigene, to provide services in clinical trials. concerns abound, however, as to whether this new subsidiary could prove to be a distraction or worse to this enzyme and pharmaceutical manufacturer. For 25 years this unofficial philosophy had served biocon well starting out in the enzyme business in 1978, the bangalore based firm had gradually expanded into the pharmaceutical industry expertise in manufacturing enzymes led to mass production of generic drugs, which in turn gave biocon the experience to establish syngene, a subsidiary.
Comments are closed.